Common Sensing develops and manufactures data-driven hardware and software solutions for people using injectable medicine.
Common Sensing develops and manufactures data-driven hardware and software medical device solutions for diabetes care that foster education and communication for patients while delivering decision support for clinicians. Common Sensing has a team of talented designers and engineers to develop Gocap™, a smart cap that turns existing injector pens into smart injectors.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 9, 2020 | Debt Financing | $1.42M | — | — | — | Detail |
Apr 10, 2019 | Debt Financing | $2M | — | — | — | Detail |
Apr 11, 2018 | Series A | $6.60M | 6 | Waterline Ventures | — | Detail |
Feb 20, 2018 | Debt Financing | $225K | — | — | — | Detail |
Jun 16, 2016 | Debt Financing | $1.65M | — | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Waterline Ventures | Yes | Series A |
Life Sciences Angel Network | Yes | Seed |
Haselmeier | — | Series A |
Koninklijke Philips | — | Series A |
New World Health | — | Series A |
Qualcomm Ventures | — | Series A |
Sanofi Ventures | — | Series A |